ResMed (RMD) Tops Q2 EPS by 6c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $220.37 -1.82%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.66, $0.06 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.03 million versus the consensus estimate of $990.85 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- ResMed names Carol Burt as lead director as Ron Taylor retires
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
